Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration

Detalles Bibliográficos
Autores principales: Giovannoni, Sara, Trenta, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195309/
https://www.ncbi.nlm.nih.gov/pubmed/25310036
http://dx.doi.org/10.3802/jgo.2014.25.4.355
_version_ 1782339292733898752
author Giovannoni, Sara
Trenta, Patrizia
author_facet Giovannoni, Sara
Trenta, Patrizia
author_sort Giovannoni, Sara
collection PubMed
description
format Online
Article
Text
id pubmed-4195309
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
record_format MEDLINE/PubMed
spelling pubmed-41953092014-10-14 Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration Giovannoni, Sara Trenta, Patrizia J Gynecol Oncol Correspondence Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2014-10 2014-10-07 /pmc/articles/PMC4195309/ /pubmed/25310036 http://dx.doi.org/10.3802/jgo.2014.25.4.355 Text en Copyright © 2014. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Giovannoni, Sara
Trenta, Patrizia
Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
title Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
title_full Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
title_fullStr Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
title_full_unstemmed Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
title_short Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
title_sort bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195309/
https://www.ncbi.nlm.nih.gov/pubmed/25310036
http://dx.doi.org/10.3802/jgo.2014.25.4.355
work_keys_str_mv AT giovannonisara bevacizumabincombinationwithgemcitabineandcarboplatininrecurrentovariancanceracriticalconsideration
AT trentapatrizia bevacizumabincombinationwithgemcitabineandcarboplatininrecurrentovariancanceracriticalconsideration

Ejemplares similares